1-4 of 4
Jürgen C. Becker
Close
Sort by
Journal Articles

Clinically Significant Responses Achieved with Romidepsin in 37 Patient with Cutaneous T-Cell Lymphoma (CTCL) with Blood Involvement.

Youn H Kim, MD, Marie-France Demierre, MD, Ellen J Kim, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Tadeusz Robak, MD, PhD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Sean Whittaker, MD, FRCP
Journal: Blood
Blood (2009) 114 (22): 2683.
https://doi.org/10.1182/blood.V114.22.2683.2683
Published: 2009
Journal Articles

Clinically Significant Responses Achieved with Romidepsin in Treatment-Refractory Cutaneous T-Cell Lymphoma: Final Results from a Phase 2B, International, Multicenter, Registration Study

Youn Kim, MD, Sean Whittaker, MD, FRCP, Marie France Demierre, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Ellen J Kim, MD, Tadeusz Robak, MD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Archibald G Prentice, MBChB, FRCP, FRCPath
Journal: Blood
Blood (2008) 112 (11): 263.
https://doi.org/10.1182/blood.V112.11.263.263
Published: 2008
Journal Articles

Phase II Trial of Oral Panobinostat (LBH589) in Patients with Refractory Cutaneous T-Cell Lymphoma (CTCL).

Madeleine Duvic, Jürgen C. Becker, Stephane Dalle, Francisco Vanaclocha, Maria Grazia Bernengo, Celeste Lebbé, Reinhard Dummer, Samit Hirawat, Lei Zhang, Miriam Marshood, Glen Laird, H. Miles Prince
Journal: Blood
Blood (2008) 112 (11): 1005.
https://doi.org/10.1182/blood.V112.11.1005.1005
Published: 2008
Journal Articles

Immunogenicity of Bcl-2 in patients with cancer

Mads Hald Andersen, Inge Marie Svane, Pia Kvistborg, Ove Juul Nielsen, Eva Balslev, Sine Reker, Jürgen C. Becker, Per thor Straten
Journal: Blood
Blood (2005) 105 (2): 728–734.
https://doi.org/10.1182/blood-2004-07-2548
Published: 2005